Abbvie (ABBV) Holder Bruce & Co INC Has Upped Its Holding

August 9, 2018 - By Matthew Richard

AbbVie Inc. (NYSE:ABBV) LogoInvestors sentiment decreased to 0.7 in 2018 Q1. Its down 0.10, from 0.8 in 2017Q4. It dropped, as 61 investors sold ABBV shares while 737 reduced holdings. 127 funds opened positions while 428 raised stakes. 1.06 billion shares or 0.67% less from 1.06 billion shares in 2017Q4 were reported. D E Shaw owns 0.22% invested in AbbVie Inc. (NYSE:ABBV) for 1.70M shares. 19,986 are held by Signaturefd Limited Liability. Usa Fincl Portformulas accumulated 34,318 shares. Gam Ag invested in 0.08% or 23,789 shares. Goelzer Inv Mgmt, a Indiana-based fund reported 44,802 shares. 182,154 are held by Clifford Swan Counsel Ltd Co. Wade G W & Incorporated holds 8,845 shares or 0.1% of its portfolio. Webster Fincl Bank N A holds 51,668 shares or 0.71% of its portfolio. Berkshire Asset Management Ltd Pa accumulated 328,133 shares. Blue Finance Cap stated it has 0.79% of its portfolio in AbbVie Inc. (NYSE:ABBV). Hartwell J M Limited Partnership holds 0.1% or 5,533 shares. Bnp Paribas Arbitrage Sa invested 0% of its portfolio in AbbVie Inc. (NYSE:ABBV). Abner Herrman & Brock Lc stated it has 6,593 shares. Sta Wealth Ltd has 5,820 shares. Ontario Teachers Pension Plan Board holds 0.1% or 67,348 shares in its portfolio.

Since February 19, 2018, it had 2 buys, and 10 insider sales for $26.21 million activity. Michael Robert A. sold $119,351 worth of AbbVie Inc. (NYSE:ABBV) on Monday, February 19. 18,129 shares were sold by RICHMOND TIMOTHY J., worth $2.15M. ALBAN CARLOS had sold 83,574 shares worth $9.57M on Wednesday, February 28. 8,280 shares were sold by GONZALEZ RICHARD A, worth $976,084. 2,643 shares valued at $311,684 were sold by SEVERINO MICHAEL on Wednesday, February 28. On Wednesday, June 20 RAPP EDWARD J bought $99,909 worth of AbbVie Inc. (NYSE:ABBV) or 1,013 shares.

Bruce & Co Inc increased its stake in Abbvie (ABBV) by 16.74% based on its latest 2018Q1 regulatory filing with the SEC. Bruce & Co Inc bought 39,000 shares as the company’s stock declined 16.83% with the market. The institutional investor held 271,915 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $25.74M, up from 232,915 at the end of the previous reported quarter. Bruce & Co Inc who had been investing in Abbvie for a number of months, seems to be bullish on the $144.20B market cap company. The stock increased 1.60% or $1.5 during the last trading session, reaching $95.23. About 1.48M shares traded. AbbVie Inc. (NYSE:ABBV) has risen 52.41% since August 9, 2017 and is uptrending. It has outperformed by 39.84% the S&P500.

More notable recent AbbVie Inc. (NYSE:ABBV) news were published by: Bizjournals.com which released: “Pharma giant on hunt for half-million square feet on Peninsula” on July 13, 2018, also Seekingalpha.com with their article: “Buying The Latest AbbVie Sell-Off With Vigor” published on July 30, 2018, Fool.com published: “Better Buy: Pfizer Inc. vs. AbbVie Inc.” on August 05, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) were released by: Seekingalpha.com and their article: “AbbVie’s Outlook Remains Blurred” published on August 07, 2018 as well as Seekingalpha.com‘s news article titled: “AbbVie Is Looking For New Growth Before Generic Competitors Roll In” with publication date: August 08, 2018.

AbbVie Inc. (NYSE:ABBV) Ratings Coverage

Among 14 analysts covering AbbVie (NYSE:ABBV), 5 have Buy rating, 2 Sell and 7 Hold. Therefore 36% are positive. AbbVie had 21 analyst reports since February 26, 2018 according to SRatingsIntel. The company was maintained on Thursday, March 22 by SunTrust. The stock of AbbVie Inc. (NYSE:ABBV) has “Buy” rating given on Friday, March 23 by Jefferies. The rating was downgraded by Piper Jaffray on Friday, June 1 to “Hold”. The company was maintained on Thursday, March 22 by Leerink Swann. BMO Capital Markets maintained AbbVie Inc. (NYSE:ABBV) rating on Wednesday, May 23. BMO Capital Markets has “Underperform” rating and $78 target. The stock of AbbVie Inc. (NYSE:ABBV) earned “Equal-Weight” rating by Morgan Stanley on Monday, April 30. The firm has “Equal-Weight” rating by Barclays Capital given on Thursday, April 5. The stock of AbbVie Inc. (NYSE:ABBV) has “Hold” rating given on Thursday, March 22 by Bernstein. The firm has “Buy” rating by Jefferies given on Monday, February 26. The stock has “Buy” rating by Bank of America on Monday, July 30.

AbbVie Inc. (NYSE:ABBV) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.